NMDA receptor subunits: function and pharmacology.
暂无分享,去创建一个
[1] P. Paoletti,et al. Modulation of Triheteromeric NMDA Receptors by N-Terminal Domain Ligands , 2005, Neuron.
[2] S. Cull-Candy,et al. Role of Distinct NMDA Receptor Subtypes at Central Synapses , 2004, Science's STKE.
[3] P. Headley,et al. NMDA antagonists and neuropathic pain--multiple drug targets and multiple uses. , 2005, Current pharmaceutical design.
[4] Karin E. Borgmann-Winter,et al. Altered neuregulin 1–erbB4 signaling contributes to NMDA> receptor hypofunction in schizophrenia , 2006, Nature Medicine.
[5] T. Yamakura,et al. Different sensitivities of NMDA receptor channel subtypes to non-competitive antagonists. , 1993, Neuroreport.
[6] K. Williams,et al. Channel blockers acting at N-methyl-D-aspartate receptors: differential effects of mutations in the vestibule and ion channel pore. , 2002, Molecular pharmacology.
[7] F. Menniti,et al. Molecular Mechanism of AMPA Receptor Noncompetitive Antagonism , 2005, Neuron.
[8] Orally efficacious NR2B-selective NMDA receptor antagonists. , 2003, Bioorganic & medicinal chemistry letters.
[9] M. Salter,et al. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury , 2005, Nature.
[10] F. Menniti,et al. Antagonists selective for NMDA receptors containing the NR2B subunit. , 1999, Current pharmaceutical design.
[11] Marc G Caron,et al. Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia , 1999, Cell.
[12] J. Kemp,et al. Identification of Critical Residues in the Amino Terminal Domain of the Human NR2B Subunit Involved in the RO 25-6981 Binding Pocket , 2003, Journal of Pharmacology and Experimental Therapeutics.
[13] R. Thompson,et al. Importance of zinc in the central nervous system: the zinc-containing neuron. , 2000, The Journal of nutrition.
[14] S. Traynelis,et al. Control of Voltage-independent Zinc Inhibition of Nmda Receptors by the Nr1 Subunit , 2022 .
[15] R. North,et al. NMDA Receptors Mediate Neuron-to-Glia Signaling in Mouse Cortical Astrocytes , 2006, The Journal of Neuroscience.
[16] D. Jane,et al. The effect of competitive antagonist chain length on NMDA receptor subunit selectivity , 2005, Neuropharmacology.
[17] H. Tse,et al. Structure–activity analysis of a novel NR2C/NR2D‐preferring NMDA receptor antagonist: 1‐(phenanthrene‐2‐carbonyl) piperazine‐2,3‐dicarboxylic acid , 2004, British journal of pharmacology.
[18] K. Williams,et al. A regulatory domain (R1-R2) in the amino terminus of the N-methyl-D-aspartate receptor: effects of spermine, protons, and ifenprodil, and structural similarity to bacterial leucine/isoleucine/valine binding protein. , 1999, Molecular pharmacology.
[19] J. Kemp,et al. Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity , 2002, The Journal of Neuroscience.
[20] J. Kemp,et al. Ionotropic and metabotropic glutamate receptor structure and pharmacology , 2005, Psychopharmacology.
[21] T. Kuner,et al. Subunit‐specific block of cloned NMDA receptors by argiotoxin636 , 1993, FEBS letters.
[22] K Williams,et al. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. , 1993, Molecular pharmacology.
[23] P. Ascher,et al. High-Affinity Zinc Inhibition of NMDA NR1–NR2A Receptors , 1997, The Journal of Neuroscience.
[24] L. Wollmuth,et al. Structure and gating of the glutamate receptor ion channel , 2004, Trends in Neurosciences.
[25] J. Kemp,et al. NMDA receptor pathways as drug targets , 2002, Nature Neuroscience.
[26] A. Fayyazuddin,et al. Molecular Organization of a Zinc Binding N-Terminal Modulatory Domain in a NMDA Receptor Subunit , 2000, Neuron.
[27] M. Mayer. Glutamate receptors at atomic resolution , 2006, Nature.
[28] T. Kuner,et al. Multiple Structural Elements Determine Subunit Specificity of Mg2+ Block in NMDA Receptor Channels , 1996, The Journal of Neuroscience.
[29] S. Lechner. Glutamate-based therapeutic approaches: inhibitors of glycine transport. , 2006, Current opinion in pharmacology.
[30] G. Collingridge,et al. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells , 1996, British journal of pharmacology.
[31] M. Mayer,et al. Crystal Structures of the Kainate Receptor GluR5 Ligand Binding Core Dimer with Novel GluR5-Selective Antagonists , 2006, The Journal of Neuroscience.
[32] Chin-Chun Lu,et al. Functional Characterization of Human N‐Methyl‐d‐Aspartate Subtype 1A/2D Receptors , 1998, Journal of neurochemistry.
[33] D. Attwell,et al. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia , 2005, Nature.
[34] P. Paoletti,et al. Relating NMDA Receptor Function to Receptor Subunit Composition: Limitations of the Pharmacological Approach , 2006, The Journal of Neuroscience.
[35] S. Schorge,et al. Studies of NMDA Receptor Function and Stoichiometry with Truncated and Tandem Subunits , 2003, The Journal of Neuroscience.
[36] B. Trapp,et al. NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia , 2006, Nature.
[37] D. Skifter,et al. Identification of Subunit- and Antagonist-Specific Amino Acid Residues in the N-Methyl-d-aspartate Receptor Glutamate-Binding Pocket , 2005, Journal of Pharmacology and Experimental Therapeutics.
[38] Bita Moghaddam,et al. Bringing Order to the Glutamate Chaos in Schizophrenia , 2003, Neuron.
[39] NMDA Receptor Subunits: Function and Pharmacology , 2007 .
[40] J. Coyle,et al. Glutamatergic mechanisms in schizophrenia. , 2003, Annual review of pharmacology and toxicology.
[41] P. Paoletti,et al. Mapping the Binding Site of the Neuroprotectant Ifenprodil on NMDA Receptors , 2002, The Journal of Neuroscience.
[42] J. Kemp,et al. A novel mechanism of activity‐dependent NMDA receptor antagonism describes the effect of ifenprodil in rat cultured cortical neurones. , 1996, The Journal of physiology.
[43] Eric Gouaux,et al. Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand‐binding core , 2003, The EMBO journal.
[44] J. Kemp,et al. Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. , 1997, The Journal of pharmacology and experimental therapeutics.
[45] H. Monyer,et al. Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors. , 1998, The Journal of biological chemistry.
[46] M. Sheng,et al. Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity , 2004, Science.
[47] K. Williams,et al. N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors. , 1997, Molecular pharmacology.
[48] M. Mayer,et al. Characterization of a Soluble Ligand Binding Domain of the NMDA Receptor Regulatory Subunit NR3A , 2006, The Journal of Neuroscience.
[49] K. Wafford,et al. Identification of Molecular Determinants That Are Important in the Assembly of N-Methyl-d-aspartate Receptors* , 2001, The Journal of Biological Chemistry.
[50] T. Yamakura,et al. Subunit- and site-specific pharmacology of the NMDA receptor channel , 1999, Progress in Neurobiology.
[51] E. Gouaux,et al. Structure of a glutamate-receptor ligand-binding core in complex with kainate , 1998, Nature.
[52] M. Kelly,et al. Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists. , 2006, Current topics in medicinal chemistry.
[53] P. Paoletti,et al. The Micromolar Zinc-Binding Domain on the NMDA Receptor Subunit NR2B , 2005, The Journal of Neuroscience.
[54] Eric Gouaux,et al. Mechanism of Partial Agonist Action at the NR1 Subunit of NMDA Receptors , 2005, Neuron.
[55] M. Mayer,et al. Mechanism of glutamate receptor desensitization , 2002, Nature.
[56] E. Gouaux,et al. Subunit arrangement and function in NMDA receptors , 2005, Nature.
[57] Joshua T Dudman,et al. Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors , 2005, The Journal of Neuroscience.
[58] S. Lipton,et al. Identification and Mechanism of Action of Two Histidine Residues Underlying High-Affinity Zn2+ Inhibition of the NMDA Receptor , 1999, Neuron.
[59] Jiankun Cui,et al. Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. , 2002, Journal of neurophysiology.
[60] R. Dingledine,et al. The glutamate receptor ion channels. , 1999, Pharmacological reviews.
[61] R. Dingledine,et al. Phenylethanolamines inhibit NMDA receptors by enhancing proton inhibition , 1998, Nature Neuroscience.
[62] M. Yuzaki,et al. Cloning and characterization of a novel NMDA receptor subunit NR3B: a dominant subunit that reduces calcium permeability. , 2002, Brain research. Molecular brain research.